在 Graves 病的治疗中,抗甲状腺药因具有广泛的适应症,不造成不可逆性甲状腺机能减退及患者易于接受等优点,故在临床上最为常用,但服药时间长及治愈率较低为其主要缺点。有关 Graves 病患者经抗甲状腺药治疗后的远期预后国外报道较多,但国内尚未见报道,本文以回顾性和前瞻性的方式对284例 Graves 病患者经硫脲类抗甲状腺药治疗后进行了随访观察和研究,现报告如下。 In the treatment of Graves disease, anti-thyroid drugs are the most commonly used in clinical practice due to their wide range of indications, non-reversible hypothyroidism and ease of acceptance by patients, but their long duration of medication and low cure rate are the major Disadvantages. The long-term prognosis of patients with Graves disease after anti-thyroid drug treatment more foreign reports, but has not been reported in China, this retrospective and prospective manner in 284 patients with Graves disease after treatment with thiourea antithyroid drugs Follow-up observation and research are as follows.